EMFO, LLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
EMFO, LLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$185,527
-48.7%
209,398
-9.2%
0.19%
-46.1%
Q3 2022$362,000
-22.0%
230,7170.0%0.34%
-26.8%
Q2 2022$464,000
-13.8%
230,7170.0%0.47%
-3.5%
Q1 2022$538,000
-47.7%
230,717
+4.3%
0.49%
-46.3%
Q4 2021$1,029,000
-42.1%
221,217
-5.1%
0.91%
-42.1%
Q3 2021$1,778,000
-46.5%
233,008
-32.1%
1.57%
-46.0%
Q2 2021$3,324,000343,0082.91%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders